UnknownNot Applicable

Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome.

150 participantsStarted 2019-02-20

Plain-language summary

Coronary artery disease (CAD) is increasing rapidly in Egyptian people and manifesting a younger age. Higher plasma low-density lipoprotein cholesterol (LDL-C), is a major predictor for the development of CAD. However, whether oxidized-LDL (ox-LDL) can be used as a risk factor for myocardial infarction (MI) has not been fully investigated. Therefore, the aim of the present study was to examine the role of ox-LDL as a risk factor for the presence and clinical outcomes in patients with MI.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients were included irrespective of concomitant risk factors for atherosclerosis such as smoking, arterial hypertension and diabetes mellitus. * Participants were both sexes. Exclusion Criteria: * Congenital heart disease. * Dilated, hypertrophic or restrictive cardiomyopathy. * acute and chronic liver disorders.

What they're measuring

The mean difference of oxidized-LDL gene polymorphism between patients and controls

Timeframe: Baseline

Trial details

NCT IDNCT03830138

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-04-01

Contact for this trial

reham elmahdy

+201002714637 reham.elmahdy@aun.edu.eg

View on ClinicalTrials.gov More Acute Coronary Syndrome trials